You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动|百济神州涨近4%收回在研抗PD-1抗体替雷利珠单抗全球授权
格隆汇 06-19 14:31
格隆汇6月19日丨百济神州(06160.HK)涨近4%,报72.4港元,成交172.57万港元,H股总市值563.8亿港元。2019年6月17日,百济神州与新基公司(CELG)达成共识,终止双方关于百济神州在研抗PD-1抗体替雷利珠单抗的全球合作,新基公司将就合作终止向百济神州支付1.5亿美元。在今年年初2018年业绩发布会上,百济对其全球商业化进展和战略曾有过介绍,其美国商业化团队已经在组建过程中,并正在针对欧洲和新市场的实际情况,评估商业化战略。由此,可以预测,替雷利珠单抗权益收回后,百济将在PD-1的商业化战略方面拥有更灵活的选择,可以结合其整体的商业化战略下,针对不同市场实际情况进行下一步布局。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account